| 1 | Cancer | 2.3% | |
| 2 | Patients | 1.64% | |
| 3 | Study | 1.64% | |
| 4 | ASCO | 1.64% | |
| 5 | Metastatic | 0.98% | |
| 6 | Risk | 0.98% | |
| 7 | Report | 0.98% | |
| 8 | Linked | 0.98% | |
| 9 | Prostate | 0.98% | |
| 10 | Phase | 0.98% | |
| 11 | Rapid | 0.66% | |
| 12 | Health | 0.66% | |
| 13 | Molecular | 0.66% | |
| 14 | Sugar | 0.66% | |
| 15 | Heart | 0.66% | |
| 16 | DNA | 0.66% | |
| 17 | Mortality | 0.66% | |
| 18 | Fat | 0.66% | |
| 19 | Therapy | 0.66% | |
| 20 | Urothelial | 0.66% | |
| 21 | pCR | 0.66% | |
| 22 | Men | 0.66% | |
| 23 | Results | 0.66% | |
| 24 | Gene | 0.66% | |
| 25 | Blood | 0.66% | |
| 26 | Cardiovascular | 0.66% | |
| 27 | Disease | 0.66% | |
| 28 | ER- | 0.33% | |
| 29 | Failure | 0.33% | |
| 30 | Calorie | 0.33% | |
| 31 | Clinical | 0.33% | |
| 32 | Situation | 0.33% | |
| 33 | Tumors | 0.33% | |
| 34 | Portfolio | 0.33% | |
| 35 | Nivolumab | 0.33% | |
| 36 | Signs | 0.33% | |
| 37 | Tied | 0.33% | |
| 38 | Clinically | 0.33% | |
| 39 | Vaccine | 0.33% | |
| 40 | CDC | 0.33% | |
| 41 | Adenotonsillectomy | 0.33% | |
| 42 | June | 0.33% | |
| 43 | (ENZA) | 0.33% | |
| 44 | Neoadjuvant | 0.33% | |
| 45 | Predicting | 0.33% | |
| 46 | (CV) | 0.33% | |
| 47 | Utilize | 0.33% | |
| 48 | Reviewed | 0.33% | |
| 49 | Outbreak | 0.33% | |
| 50 | Safety | 0.33% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||